Global University Venturing

Karolinska Development-backed Biosergen has begun trading on the Nasdaq First Growth Market, having already undertaken a $5.9m offering earlier this month.

Existing shareholder Suez Group has acquired Imperial College spinout Inflowmatix, providing exits to IP Group and Parkwalk Advisors.

Partly based on research at University of Washington, KenSci has agreed to an acquisition by Tegria for an undisclosed sum.

University of Oxford and OSI are set to exit the medical diagnostics software provider in a flotation with a $75m placeholder target.

Third Rock Ventures has led a series A round for Abata Therapeutics, launched by the firm to commercialise research from Harvard, MIT, Johns Hopkins, NIH and UZH.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Gene therapy developer Corlieve, which utilises University of Bordeaux, Aix Marseille University, CNRS and Inserm research, is set to be acquired by peer QniQure for about $55m.

Allied Minds had invested over $50m in New York University RAM technology spinout Spin Memory, which has decided to liquidate its assets to pay creditors.

Harvard-aligned venture capital firm Xfund has reinvested in ImmuneID, which is developing precision immunology therapies based on Harvard University and Johns Hopkins University research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MIT mRNA therapeutics spinout Strand has secured series A funding from BeiGene, Redmile Group, Camford Capital, Playground Global and Anri.